Detalhe da pesquisa
1.
Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
J Oral Maxillofac Surg
; 70(8): 1844-53, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22595135
2.
Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure.
J Oral Maxillofac Surg
; 68(9): 2232-40, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20728032
3.
Characteristics of implant failures in patients with a history of oral bisphosphonate therapy.
J Oral Maxillofac Surg
; 68(3): 508-14, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20171469
4.
Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure.
J Oral Maxillofac Surg
; 68(2): 243-53, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19772941
5.
Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
J Oral Maxillofac Surg
; 67(7): 1363-72, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19531404
6.
Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.
Bone
; 51(3): 524-7, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22634175
7.
Oral health considerations in older women receiving oral bisphosphonate therapy.
J Am Geriatr Soc
; 59(5): 916-22, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21539523